Phase I dose-escalation study of the pan-PI3 K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors

M. Macy, T. Cash, N. Pinto, J. G. Pressey, L. Szalontay, W. L. Furman, A. Bukowinski, J. H. Foster, G. K. Friedman, J. HaDuong, E. Fox, B. J. Weigel, J. Grevel, F. Huang, C. Phelps, B. H. Childs, J. Chung, S. Chaturvedi, A. Schulz, S. G. DuBois

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)S28-S29
JournalEuropean Journal of Cancer
Volume174
DOIs
StatePublished - Oct 2022

Cite this